ServiceNow to Present at Upcoming Investor Conferences

SANTA CLARA, Calif.--(BUSINESS WIRE)-- ServiceNow (NYSE: NOW) today announced that it will attend and have executives present at three upcoming investor conferences. These include:

• ServiceNow Chief Financial Officer, Gina Mastantuono, will participate in a fireside chat at Deutsche Bank’s 2022 Technology Conference on Thursday, September 1 at 11:00 a.m. PT. Individuals may access the live webcast of the presentation here.
• ServiceNow Chief Financial Officer, Gina Mastantuono, will participate in a fireside chat at Citi’s 2022 Global Technology Conference on Thursday, September 8 at 11:30 a.m. PT. Individuals may access the live webcast of the presentation here.
• ServiceNow President and Chief Executive Officer, Bill McDermott, will present at the 2022 Goldman Sachs Communacopia + Technology Conference on Wednesday, September 14 at 1:15 p.m. PT. Individuals may access the live webcast of the presentation here.

The live webcasts will be accessible on the investor relations section of the ServiceNow website at http://investors.servicenow.com and archived on the ServiceNow site for a period of 30 days.

About ServiceNow

ServiceNow (NYSE: NOW) makes the world work better for everyone. Our cloud‑based platform and solutions help digitize and unify organizations so that they can find smarter, faster, better ways to make work flow. So employees and customers can be more connected, more innovative, and more agile. And we can all create the future we imagine. The world works with ServiceNowTM. For more information, visit: www.servicenow.com.

© 2022 ServiceNow, Inc. All rights reserved. ServiceNow, the ServiceNow logo, Now, and other ServiceNow marks are trademarks and/or registered trademarks of ServiceNow, Inc. in the United States and/or other countries. Other company names, product names, and logos may be trademarks of the respective companies with which they are associated.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220825005253/en/

Media Contact:
Sara Day
650.336.3123
[email protected]

Investor Contact:
Darren Yip
925.388.7205
[email protected]

Source: ServiceNow

You May Also Be Interested In

• ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer
• Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025
• Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer